Literature DB >> 1541519

Effect of lectins on hepatic clearance and killing of Candida albicans by the isolated perfused mouse liver.

R T Sawyer1, R E Garner, J A Hudson.   

Abstract

The isolated perfused mouse liver model was used to study the effects of various lectins on hepatic trapping and killing of Candida albicans. After mouse livers were washed with 20 to 30 ml of perfusion buffer, 10(6) C. albicans CFU were infused into the livers. At the time of recovery, 63% +/- 2% (mean +/- standard error of the mean) of the infused C. albicans CFU were recovered from the liver and 14% +/- 1% were recovered from the effluent for a total recovery of 77% +/- 2%. This indicated that 86% +/- 9% of the original inoculum was trapped by the liver and that 23% +/- 2% was killed within the liver. When included in both preperfusion and postperfusion buffers (0.2 mg of lectin per ml), Ulex europeaus lectin (binding specificity for fucose) decreased hepatic trapping of C. albicans by 37% and eluted trapped C. albicans from the liver only when included in postperfusion buffer. By comparison, treatment of C. albicans with U. europeaus lectin before infusion had no effect on the trapping or killing of yeast cells. When Lens culinaris lectin (binding specificity for mannose) was included in the perfusion buffers, hepatic killing of C. albicans increased by 16% with no significant effect on hepatic killing when yeast cells were treated with L. culinaris lectin before infusion. Forty to 55% of the infused C. albicans were killed when concanavalin A (binding specificities for mannose and glucose), Glycine max (binding specificity for N-acetylgalactosamine), or Arachis hypogea (binding specificity for galactose) lectin was included in the perfusion buffer or when yeast cells were treated with these lectins before their infusion. When C. albicans was treated with concanavalin A at a concentration of less than 0.02 mg/ml, hepatic killing of yeast cells was not significantly increased. The data suggest that a fucose-containing receptor on the surface of either sinusoidal endothelial cells or Kupffer cells is involved in the trapping of C. albicans by the perfused mouse liver. Moreover, lectins with binding specificities for mannose, N-acetylgalactosamine, and galactose increased hepatic killing of C. albicans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541519      PMCID: PMC257591          DOI: 10.1128/iai.60.3.1041-1046.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

2.  In situ separation of bacterial trapping and killing functions of the perfused liver.

Authors:  R J Moon; R A Vrable; J A Broka
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

3.  The effect of monosaccharides on in situ hepatic trapping of Candida albicans.

Authors:  R T Sawyer
Journal:  Mycopathologia       Date:  1988-11       Impact factor: 2.574

4.  Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers.

Authors:  R T Sawyer; R J Moon; E S Beneke
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

5.  Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism.

Authors:  J Patterson-Delafield; R J Martinez; R I Lehrer
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

6.  Phagocytosis and intracellular disposition of viable bacteria by the isolated perfused rat liver.

Authors:  P F Bonventre; E Oxman
Journal:  J Reticuloendothel Soc       Date:  1965-11

7.  The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

8.  Hepatic clearance of Candida albicans in rats.

Authors:  R T Sawyer; R J Moon; E S Beneke
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

9.  Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon.

Authors:  K Watanabe; K Kagaya; T Yamada; Y Fukazawa
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

10.  Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes.

Authors:  R I Lehrer; K M Ladra; R B Hake
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

View more
  6 in total

Review 1.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

2.  Intravenous injection of Candida-derived mannan results in elevated tumor necrosis factor alpha levels in serum.

Authors:  R E Garner; J A Hudson
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Concanavalin A protects mice from a lethal inoculation of intragastric Klebsiella pneumoniae and reduces the induced liver damage.

Authors:  Chih-Feng Kuo; Ya-Hui Wang; Huan-Yao Lei; Chiou-Huey Wang; Nina Tsao
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

Review 4.  Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo.

Authors:  P F Lalor; W K Lai; S M Curbishley; S Shetty; D H Adams
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

5.  Candida albicans-derived mannoproteins activate NF-κB in reporter cells expressing TLR4, MD2 and CD14.

Authors:  Traci Ness; Mahmud Abdallah; Jaime Adams; Claudia Alvarado; Edwin Gunn; Brittany House; John Lamb; Jack Macguire; Emily Norris; Rebekah Robinson; Morgan Sapp; Jill Sharma; Ronald Garner
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

6.  Mucosal damage and neutropenia are required for Candida albicans dissemination.

Authors:  Andrew Y Koh; Julia R Köhler; Kathleen T Coggshall; Nico Van Rooijen; Gerald B Pier
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.